IL20RA and cancer: In contrast, the WNT5A+ inflammatory fibroblast interacts with cancer cells via IL24:IL20RA and WNT5A:FZD5 pathways, which could promote cancer progression and chemoresistance39,40 (Fig. 4D and Supplementary Fig. S12E).